Antabio
ID: 17664216Developer of MEM-ANT3310, a next generation antibacterial combination.
4
Funding Rounds
$42.7m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Antabio has raised a total of $42.7m in funding over 4 rounds.
Key Insights:
- Antabio December 2023 Series B Funding Round: $27m
- Antabio Sas Series A round, July 2018: $14.6m
- Antabio December 2014 Seed Funding Round: $98.14k
- Antabio February 2011 Seed Funding Round: $1m
Industries
Antabio is active in the following industries: